Monographie - Ketorolac tromethamine

Viimeisin päivitys :
08/05/2024

Ketorolac tromethamine

Kemiallinen rakenne

Kauppanimi

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Bedoral	Etelä-Afrikka
Ketorolac trometamol	Iso-Britannia
Lixidol	Italia
Taradyl	Belgia
Toradol	Espanja, Iso-Britannia, Italia, Norja, Ruotsi, Suomi, Tanska

Viitteet : Ketorolac tromethamine

	Tyyppi	Julkaisu
59	Lehti	Trissel LA, Gilbert DL, Martinez JF, Kim MC. Compatibility of remifentanil hydrochloride with selected drugs during simulated Y-site administration. Am J Health-Syst Pharm 1997 ; 54: 2192-2196.
216	Lehti	Huang E, Anderson RP. Compatibility of hydromorphone hydrochloride with haloperidol lactate and ketorolac tromethamine. Am J Hosp Pharm 1994 ; 51: 2963.
228	Lehti	Mendenhall A, Hoyt DB. Incompatibility of ketorolac tromethamine with haloperidol lactate and triethylperazine maleate. Am J Hosp Pharm 1994 ; 51: 2964.
299	Lehti	Trissel LA, Martinez JF, Gilbert DL. Compatibility of cisatracurium besylate with selected drugs during simulated Y-site administration. Am J Health-Syst Pharm 1997 ; 54: 1735-1741.
451	Lehti	Das Gupta V, Maswoswe J, Bailey RE. Stability of ketorolac tromethamine in 5% dextrose injection and 0.9% sodium chloride injections. Int J Pharm Compound 1997 ; 1: 206-207.
469	Lehti	Floy BJ, Royko CJ, Fleitman JS. Compatibility of ketorolac tromethamine injection with common infusion fluids and administration sets. Am J Hosp Pharm 1990 ; 47: 1097-1100.
476	Lehti	Knapp AJ, Mauro VF, Alexander KS. Incompatibility of ketorolac tromethamine with selected postoperative drugs. Am J Hosp Pharm 1992 ; 49: 2960-2962.
1634	Lehti	Shi A, Walker SE, Law S. Stability of ketorolac tromethamine in IV solutions and waste reduction. Can J Hosp Pharm 2000 ; 53: 263-269.
1712	Lehti	Trissel LA, Saenz CA. Compatibility screening of Precedex during simulated Y-site administration with other drugs. Int J Pharm Compound 2002 ; 6: 230-233.
1721	Lehti	Trissel LA, Williams KY, Baker MB. Compatibility screening of Hextend during simulated Y-site administration with other drugs. Int J Pharm Compound 2001 ; 5: 69-72.
1800	Lehti	Voytilla KL, Tyler LS, Rusho WJ. Visual compatibility of azithromycin with 24 commonly used drugs during simulated Y-site delivery. Am J Health-Syst Pharm 2002 ; 59: 853-855.
1803	Lehti	Trissel, LA, Saenz CA, Ogundele OB, Ingram D, Baker MB. Compatibility of fenoldopam mesylate with other drugs during simulated Y-site administration. Am J Health-Syst Pharm 2003 ; 60: 80-85.
1859	Lehti	Anacardio R, Perilli O, Pagnanelli F, Bartolini S, gentile MM, Mazzeo P, Carlucci G. Physicochemical compatibility between thiocolchicoside injections (Miotens®) and pharmaceutical products frequently used for combined therapy. Il Farmaco 2002 ; 57: 925-930.
1974	Lehti	Chandler SW, Trissel LA, Weinstein SM Combined administration of opoids with selected drugs to manage pain and other cancer symptoms initial safety screening for compatibility. J Pain Symptom Manage 1996 ; 12, 3: 168-171.
2015	Lehti	Hecq JD, Boitquin LP, Vanbeckbergen DF, Jamart J, Galanti LM. Effect of freezing, long term storage, and microwave thawing on the stability of ketorolac tromathamine. Ann Pharmacotherapy 2005 39: 1654-1658.
2124	Lehti	Hecq JD, Boitquin L, Lebrun C, Vanbeckbergen D, Evrard JM, Jamart J, Galanti L. Freeze thaw treatment of ketorolac tromethamine in 5% dextrose infusion polyolein bags: effect of drug concentration and microwave power on the long-term stability at 4°C. EJHP Science 2006 ; 12, 4: 72-75.
2166	Lehti	Nassr S, Dubuc MC, Lavoie P, Brazier JL. HPLC-DAD methods for studying the stability of solutions containing hydromorphone, ketorolac, haloperidol, midazolam, famotidine, metoclopramide, dimenhydrinate and scopolamine. J Liquid Chrom Rel Technol 2003 ; 26, 17: 2909-2929.
3159	Lehti	Lin, T.-F., Lin, F.-S., Chou, W.-H., Yeh, Y.-C., Lin, C.-P., Fan, S.-Z., Sun, W.-Z. Compatibility and stability of binary mixtures of ketorolac tromethamine and tramadol hydrochloride injection concentrate and diluted infusion solution. Acta Anaesthesiol Taiwan 2010 ; 48, 3 : 117-121.
3169	Lehti	Raffaeli W, Pari G, Visani L et al. Experimentation about precipitation of pharmacological association: morphine and ketorolac. Pain Clinic 1999 ; 11: 213-216.
3374	Lehti	Smith R.P.R, Jones M. Precipitation in Manchester: ketorolac/cyclizine Anaesthesia 2001 ; 56: 494-495.
3470	Lehti	Destro M, Ottolini L, Vicentini L, Boschetti S. Physical compatibility of binary and tertiary mixtures of morphine and methadone with other drugs for parenteral administration in palliative care. Support Care Cancer 2012 ; 20: 2501-2509.
3571	Lehti	Anderson C, Boehme S, Ouellette J, Stidham C, MacKay M. Physical and Chemical Compatibility of Injectable Acetaminophen During Simulated Y-Site Administration. Hosp Pharm 2014 ; 49, 1: 42-47.
3593	Laboratorio	Ketorolac trometamol (Ketorolac®) - Summary of Product Characteristics Beacon Pharmaceuticals 2011
3601	Laboratorio	Cisatracurium Actavis - Résumé des Caractéristiques du Produit Actavis 2012
4433	Lehti	Ghazi I.M, El Nekidy W.S, Sood A, Dulku A, Patel R, Patel K. Y-site Administration of Imipenem/Cilastatin/ Relebactam With Common Intravenous Medications Clin Ther 2020 ; 42, 3: 475-485.
4435	Lehti	Hanifah S, Nugroho B.H, Chabib L. Compatibility of acetaminophen with central nervous system medications during simulated Y-site injection. Anaesthesiol Intensive Ther 2020 ; 52, 1: 23-27.

Mentions Légales